• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多系统萎缩的小脑和帕金森病表型:相似性、差异性和生存率。

Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.

机构信息

Department of Neurology, Dysautonomia Center, New York University School of Medicine, 530 First Avenue, Suite 9Q, New York, NY, 10016, USA.

出版信息

J Neural Transm (Vienna). 2014 May;121(5):507-12. doi: 10.1007/s00702-013-1133-7. Epub 2013 Dec 15.

DOI:10.1007/s00702-013-1133-7
PMID:24337696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4134009/
Abstract

Multiple system atrophy (MSA) is a neurodegenerative disease with two motor phenotypes: parkinsonian (MSA-P) and cerebellar (MSA-C). To elucidate whether in addition to the motor abnormalities there are other significant differences between these phenotypes, we performed a retrospective review of 100 patients (61 males, 39 females) with a diagnosis of possible (12 %), or probable (88 %) MSA. Four patients eventually had post-mortem confirmation (i.e., definite MSA). Sixty percent were classified as having MSA-P and 40 % as MSA-C. MSA-C and MSA-P patients had similar male prevalence (60 %), age of onset (56 ± 9 years), and frequency of OH (69 %). Brain MRI abnormalities were more frequent in MSA-C patients (p < 0.001). Mean survival was 8 ± 3 years for MSA-C and 9 ± 4 years for MSA-P patients (p = 0.22). Disease onset before 55 years predicted longer survival in both phenotypes. Initial autonomic involvement did not influence survival. We conclude that patients with both motor phenotypes have mostly similar survivals and demographic distributions. The differences here identified could help counseling of patients with MSA.

摘要

多系统萎缩(MSA)是一种神经退行性疾病,有两种运动表型:帕金森型(MSA-P)和小脑型(MSA-C)。为了阐明除了运动异常之外,这些表型之间是否还有其他显著差异,我们对 100 名可能(12%)或可能(88%)MSA 的患者进行了回顾性审查。4 名患者最终进行了尸检确认(即明确的 MSA)。60%的患者被归类为 MSA-P,40%的患者为 MSA-C。MSA-C 和 MSA-P 患者的男性患病率(60%)、发病年龄(56±9 岁)和 OH 频率(69%)相似。MSA-C 患者的脑 MRI 异常更为常见(p<0.001)。MSA-C 和 MSA-P 患者的平均存活时间分别为 8±3 年和 9±4 年(p=0.22)。两种表型中,发病年龄<55 岁预测存活时间更长。初始自主神经受累并不影响生存。我们的结论是,两种运动表型的患者的存活率和人口统计学分布大多相似。这里确定的差异可能有助于对 MSA 患者进行咨询。

相似文献

1
Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.多系统萎缩的小脑和帕金森病表型:相似性、差异性和生存率。
J Neural Transm (Vienna). 2014 May;121(5):507-12. doi: 10.1007/s00702-013-1133-7. Epub 2013 Dec 15.
2
Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients.多系统萎缩的病情进展与预后:对230例日本患者的分析
Brain. 2002 May;125(Pt 5):1070-83. doi: 10.1093/brain/awf117.
3
Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital.在拉巴特大学医院的运动障碍门诊就诊的摩洛哥患者中的多系统萎缩特征。
Rev Neurol (Paris). 2013 Feb;169(2):121-5. doi: 10.1016/j.neurol.2012.04.006. Epub 2012 Jul 2.
4
Natural history of multiple system atrophy in the USA: a prospective cohort study.美国多系统萎缩的自然史:一项前瞻性队列研究。
Lancet Neurol. 2015 Jul;14(7):710-9. doi: 10.1016/S1474-4422(15)00058-7. Epub 2015 May 27.
5
[Multiple system atrophy].[多系统萎缩]
Psychol Neuropsychiatr Vieil. 2010 Sep;8(3):179-91. doi: 10.1684/pnv.2010.0212.
6
MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.MSA-C是日本MSA的主要临床表型:对142例可能患有MSA的患者的分析。
J Neurol Sci. 2006 Nov 15;249(2):115-21. doi: 10.1016/j.jns.2006.05.064. Epub 2006 Jul 10.
7
Dystonia in multiple system atrophy.多系统萎缩中的肌张力障碍
J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):300-3. doi: 10.1136/jnnp.72.3.300.
8
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.尸检证实了多个系统萎缩病例:梅奥经验和自主功能测试的作用。
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):453-9. doi: 10.1136/jnnp-2011-301068. Epub 2012 Jan 6.
9
[Prognostic factors for inability to walk independently in patients with multiple system atrophy].[多系统萎缩患者无法独立行走的预后因素]
Zhonghua Nei Ke Za Zhi. 2017 Feb 1;56(2):94-98. doi: 10.3760/cma.j.issn.0578-1426.2017.02.003.
10
[Expanding concept of clinical conditions and symptoms in multiple system atrophy].[多系统萎缩临床病症及症状的扩展概念]
Rinsho Shinkeigaku. 2016 Jul 28;56(7):457-64. doi: 10.5692/clinicalneurol.cn-000903. Epub 2016 Jun 30.

引用本文的文献

1
Predictive clinical factors for the progression from idiopathic late-onset cerebellar ataxia to multiple system atrophy cerebellar type.从特发性迟发性小脑共济失调进展为多系统萎缩小脑型的预测性临床因素。
J Neurol. 2025 Aug 7;272(9):561. doi: 10.1007/s00415-025-13292-w.
2
A meta-analysis of survival and prognostic factors in multiple system atrophy.多系统萎缩生存及预后因素的荟萃分析
J Neurol. 2025 Jun 18;272(7):467. doi: 10.1007/s00415-025-13204-y.
3
Neurofilament Light Chain in Cerebrospinal Fluid and Blood in Multiple System Atrophy: A Systematic Review and Meta-Analysis.多系统萎缩患者脑脊液和血液中的神经丝轻链:一项系统评价和荟萃分析
Brain Sci. 2025 Feb 25;15(3):241. doi: 10.3390/brainsci15030241.
4
Nature of Parkinsonian features in multiple system atrophy.多系统萎缩中帕金森氏症特征的本质
J Neurosci Rural Pract. 2024 Apr-Jun;15(2):211-216. doi: 10.25259/JNRP_445_2023. Epub 2023 Dec 16.
5
Sex-related differences in the clinical presentation of multiple system atrophy.多系统萎缩的临床表现在性别上的差异。
Clin Auton Res. 2024 Apr;34(2):253-268. doi: 10.1007/s10286-024-01028-1. Epub 2024 Apr 17.
6
The potential of phosphorylated α-synuclein as a biomarker for the diagnosis and monitoring of multiple system atrophy.磷酸化 α-突触核蛋白作为多系统萎缩诊断和监测标志物的潜力。
CNS Neurosci Ther. 2024 Apr;30(4):e14678. doi: 10.1111/cns.14678.
7
Corneal confocal microscopy may help to distinguish Multiple System Atrophy from Parkinson's disease.角膜共焦显微镜检查可能有助于鉴别多系统萎缩与帕金森病。
NPJ Parkinsons Dis. 2024 Mar 16;10(1):63. doi: 10.1038/s41531-024-00680-8.
8
Development and Validation of a Prognostic Model to Predict Overall Survival in Multiple System Atrophy.预测多系统萎缩总生存期的预后模型的开发与验证
Mov Disord Clin Pract. 2023 Jul 17;10(9):1368-1376. doi: 10.1002/mdc3.13822. eCollection 2023 Sep.
9
Sex differences in alpha-synucleinopathies: a systematic review.α-突触核蛋白病中的性别差异:一项系统综述。
Front Neurol. 2023 Jul 20;14:1204104. doi: 10.3389/fneur.2023.1204104. eCollection 2023.
10
Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?帕金森病的磁共振成像和核医学成像:我们的下一步在哪里?
Curr Neuropharmacol. 2024;22(10):1583-1605. doi: 10.2174/1570159X21666230801140648.

本文引用的文献

1
The natural history of multiple system atrophy: a prospective European cohort study.多系统萎缩的自然史:一项前瞻性欧洲队列研究。
Lancet Neurol. 2013 Mar;12(3):264-74. doi: 10.1016/S1474-4422(12)70327-7. Epub 2013 Feb 5.
2
Multiple system atrophy with prolonged survival.
Mov Disord. 2012 Dec;27(14):1834. doi: 10.1002/mds.25289. Epub 2012 Dec 5.
3
Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch.多系统萎缩-帕金森病,进展缓慢,生存期延长:一个诊断陷阱。
Mov Disord. 2012 Aug;27(9):1186-90. doi: 10.1002/mds.25115. Epub 2012 Jul 17.
4
Assessment of the Scopa-Aut questionnaire in multiple system atrophy: relation to UMSARS scores and progression over time.Scopa-Aut 问卷在多系统萎缩中的评估:与 UMSARS 评分的关系及随时间的进展。
Parkinsonism Relat Disord. 2012 Jun;18(5):612-5. doi: 10.1016/j.parkreldis.2011.12.009. Epub 2012 Jan 9.
5
Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests.尸检证实了多个系统萎缩病例:梅奥经验和自主功能测试的作用。
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):453-9. doi: 10.1136/jnnp-2011-301068. Epub 2012 Jan 6.
6
Modelling progressive autonomic failure in MSA: where are we now?MSA 中进行进行性自主神经衰竭建模:我们现在在哪里?
J Neural Transm (Vienna). 2011 May;118(5):841-7. doi: 10.1007/s00702-010-0576-3. Epub 2011 Jan 8.
7
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.欧洲多系统萎缩的表现、诊断和治疗:欧洲多系统萎缩注册研究的最终分析。
Mov Disord. 2010 Nov 15;25(15):2604-12. doi: 10.1002/mds.23192.
8
Second consensus statement on the diagnosis of multiple system atrophy.关于多系统萎缩诊断的第二篇共识声明。
Neurology. 2008 Aug 26;71(9):670-6. doi: 10.1212/01.wnl.0000324625.00404.15.
9
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.进行性核上性麻痹和多系统萎缩的临床结局
Brain. 2008 May;131(Pt 5):1362-72. doi: 10.1093/brain/awn065. Epub 2008 Apr 2.
10
Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.自主神经功能障碍的早期发展可能预示着多系统萎缩患者的预后不良。
Arch Neurol. 2007 Feb;64(2):256-60. doi: 10.1001/archneur.64.2.256.